Coronary heart disease secondary prevention: Difference between revisions
No edit summary |
|||
(86 intermediate revisions by 6 users not shown) | |||
Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | == Overview == | ||
Patients who should be treated with secondary prevention are those with established atherosclerosis including peripheral artery | |||
disease; carotid artery disease; atherosclerotic aortic disease; diabetes and those with a Framingham Risk Score of > 20%. | |||
There are 12 aspects of secondary prevention: Smoking cessation; blood pressure control; lipid-lowering; increasing physical activity; weight loss; diabetes control; antiplatelet agents/anticoagulants; RAS blockers; beta-blockers; depression management; cardiac rehabilitation and influenza vaccine. Please note that secondary prevention guidelines, especially, those involving medication, may differ between [[Unstable Angina|UA/NSTEMI]]; [[STEMI]]; and [[Chronic Stable Angina]]. Please refer to appropriate page for more specific guidelines. | |||
==Lipid Management== | ==[[Coronary heart disease secondary prevention target population | Target Population]]== | ||
==[[Coronary heart disease secondary prevention patient education | Patient Education]]== | |||
==[[Coronary heart disease secondary prevention smoking cessation | Smoking Cessation]]== | |||
==[[Coronary heart disease secondary prevention blood pressure control | Blood Pressure Control]]== | |||
==[[Coronary heart disease secondary prevention lipid management | Lipid Management]]== | |||
==[[Coronary heart disease secondary prevention physical activity recommendations | Physical Activity Recommendations]]== | |||
==[[Coronary heart disease secondary prevention weight management | Weight Management]]== | |||
==[[Coronary heart disease secondary prevention influenza vaccination | Influenza Vaccination]]== | |||
==[[Coronary heart disease secondary prevention depression | Depression]]== | |||
==[[Coronary heart disease secondary prevention beta-blockers | Beta Blockers]]== | |||
==[[Coronary heart disease secondary prevention diabetes mellitus management | Diabete Mellitus Management]]== | |||
==[[Coronary heart disease secondary prevention antiplatelet agents/anticoagulants | Antiplatelet Agents/Anticoagulants]]== | |||
==[[Coronary heart disease secondary prevention renin-angiotensin-aldosterone system blockers |Renin-angiotensin-aldosterone system blockers]]== | |||
==[[Coronary heart disease secondary prevention cardiac rehabilitation | Cardiac Rehabilitation]]== | |||
==References== | |||
{{reflist|2}} | |||
[[Category:Cardiology]] | |||
[[Category:Disease]] | |||
{{WH}} | |||
{{ | {{WS}} |
Latest revision as of 20:53, 8 January 2013
Coronary heart disease Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Coronary heart disease secondary prevention On the Web |
American Roentgen Ray Society Images of Coronary heart disease secondary prevention |
Risk calculators and risk factors for Coronary heart disease secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Patients who should be treated with secondary prevention are those with established atherosclerosis including peripheral artery disease; carotid artery disease; atherosclerotic aortic disease; diabetes and those with a Framingham Risk Score of > 20%. There are 12 aspects of secondary prevention: Smoking cessation; blood pressure control; lipid-lowering; increasing physical activity; weight loss; diabetes control; antiplatelet agents/anticoagulants; RAS blockers; beta-blockers; depression management; cardiac rehabilitation and influenza vaccine. Please note that secondary prevention guidelines, especially, those involving medication, may differ between UA/NSTEMI; STEMI; and Chronic Stable Angina. Please refer to appropriate page for more specific guidelines.